Rate of Blood Pressure Control Among Hypertensive Patients With Hemodialysis in Sohag University Hospital

May 29, 2024 updated by: Hager Abdo Mohamed

The goal of this Cross-sectional study is to detect hypertensive patients with hemodialysis in Sohag University Hospital and controlled patients and noncontrolled patients. The main questions it aims to answer are:

  1. What is the pattern of blood pressure control among patients receiving hemodialysis?
  2. What are factors associated with successful blood pressure control?
  3. What is the level of patient knowledge and awareness regarding blood pressure management?
  4. What are the challenges and barriers faced by patients in achieving optimal blood pressure control? Participants Blood pressure calculated by taking the average of three consecutive days measurement.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

  1. Survey Type: Cross-sectional study.
  2. Target Population: Patients undergoing hemodialysis.
  3. Sample Size: The target sample size are all hypertensive patients in Sohag university hospital dialysis unit
  4. Survey Method: person to person interview in dialysis units will be used for data collection.

Blood pressure calculated by taking the average of three consecutive days

  • 1st day (Dialysis Day): - Blood pressure will be measured (pre dialysis, inter dialysis, post dialysis).
  • 2nd day (Inter Dialytic Day): - Blood pressure will be measured two times (AM, PM).
  • 3rd day (Dialysis Day): - Blood pressure will be measured (pre dialysis, inter dialysis, post dialysis).

Study Type

Observational

Enrollment (Estimated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Egypt
      • Sohag, Egypt, 82524
        • Faculty of medicine sohag university
        • Contact:
        • Principal Investigator:
          • Hager A Mohamed, M.B.B.CH

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

hypertensive patients with hemodialysis in Sohag University Hospital

Description

Inclusion Criteria:

- Participants must be

  • 18 years or older.
  • currently receiving hemodialysis.
  • Hypertensive patients.

Exclusion Criteria:

  • patients under 18 years old.
  • Patients stopped hemodialysis.
  • Patients with ESRD not receiving hemodialysis.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Rate of blood pressure control among hypertensive patients with hemodialysis in Sohag University Hospital with hemodialysis in Sohag University Hospital
Time Frame: 3 days
3 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hager Abdo Mohamed

Investigators

  • Study Chair: Hassan A Hassanien, professor, Sohag University
  • Study Chair: Alaa A Ghaleb, professor, Sohag University
  • Study Chair: Ahmed N Nour Eldin, Lecturer, Sohag University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 24, 2024

Primary Completion (Estimated)

December 20, 2024

Study Completion (Estimated)

December 20, 2024

Study Registration Dates

First Submitted

May 21, 2024

First Submitted That Met QC Criteria

May 21, 2024

First Posted (Actual)

May 28, 2024

Study Record Updates

Last Update Posted (Actual)

May 31, 2024

Last Update Submitted That Met QC Criteria

May 29, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Sohagu.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe